Xiang C.

Xiang (Sean) C. is an experienced regulatory affairs professional with a strong background in Chemistry and a focus on biologics. Currently serving as Associate Director in Regulatory Affairs CMC at Daiichi Sankyo, Inc., Xiang leads regulatory strategy and BLA submissions for advanced drug products and manages interactions with external CMOs and Health Authorities. Prior experience includes roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, where Xiang developed CMC strategies for biologics programs and authored key regulatory documents, and at Bristol-Myers Squibb, where analytical sub-team management and project management were key responsibilities. Xiang holds a Ph.D. in Chemistry from Purdue University and a Bachelor's degree in Chemical Physics from the University of Science and Technology of China.